BNF:

3.2

Status:

Grey

Decision Date:

None

Comments

Restricted for use in patients who cannot tolerate other inhaled corticosteroids and if a once daily preparation is clinically appropriate for the patient or following respiratory specialist advice as an add-on to current LABA/ICS.  (Decision date - February 2016, further decision - October 2019).

Grey Drug Classifications

• 1: Lack of data on effectiveness compared with standard therapy
• 5: Less cost-effective than current standard therapy

search again